Gu et al. (Gu et al., 2021) reported that a high co-expression level of DMDRMR (a novel DNA methylation-deregulated and RNA m6A reader-cooperating lncRNA) and IGF2BP3 is associated with poor prognosis in RCC patients. The gene discussed is IGF2BP3; the disease is renal cell adenocarcinoma.